Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: An Italian randomized controlled trial

Anticancer Research

Volumn 31, Issue 6, 2011, Pages 2291-2295

  Giorgio, Antonio ^a   Di Sarno, A ^a   De Stefano, G ^a   Scognamiglio, U ^a   Farella, N ^a   Mariniello, A ^a   Esposito, V ^a   Coppola, C ^a   Giorgio, V ^a  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Percutaneous ablation; Percutaneous ethanol injection; Radiofrequency ablation; Randomized controlled trial

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; COMPLICATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COST-BENEFIT ANALYSIS; DRUG COSTS; ETHANOL; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE;

EID: 79960438428     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Giorgio A: Percutaneous radiofrequency ablation of Hepatocellular carcinoma on cirrhosis: state of the art and future perspectives. Recent Pat Anticancer Drug Discov 5: 69-76, 2010.
2. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M and Rodés J: Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL Conference. J Hepatol 35(3): 421-430, 2001. (Pubitemid 32844200)
3. Orlando A, Leandro G, Olivo M, Andriulli A and Cottone M: Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: metanalysis of randomized controller trials. Am J Gastroenterol 104(2): 514-524, 2009.
4. Cho YK, Kim JK, Kim MY, Rhim H and Han JK: Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49(2): 453-459, 2009.
5. Bouza C, Cuadrado TL, Alcàzar R, Parkinson ZS and Amate JM: Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 9: 31-39, 2009.
6. Germani G, Pleguezuelo M, Gurusamy K, Meyer Isgrò G and Burroughs AK: Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular carcinoma: a meta-analysis. J Hepatol 52(3): 380-388, 2010.
7. Lin SM, Lin CJ, Lin CC, Hsu CW and Chen YC: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma <4 cm. Gastroenterology 127: 1714-1723, 2004.
8. Lin SM, Lin CJ, Lin CC, Hsu CW and Chen YC: Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid to treat hepatocellular carcinoma of 3 cm or less. Gut 54: 1151-1156, 2005.
9. Shiina S, Teratoni T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T and Omata M: A randomised controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129: 122-130, 2005. (Pubitemid 41002049)
10. Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, Sacchetto P, Gandini G and Rizzetto M: Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 43(6): 727-735, 2008.
11. Bruix J and Sherman M: Management of hepatocellular carcinoma. Hepatology 42: 1208-1236, 2005.
12. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S and Torzilli G: Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197: 101-108, 1995.
13. Giorgio A, Tarantino L, de Stefano G, Perrotta A, Aloisio V, del Viscovo L, Alaia A and Lettieri G: Ultrasound-guided percutaneous ethanol injection under general anaesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients. Eur J Ultrasound 12: 145-154, 2000.
14. Giorgio A, Tarantino L, de Stefano G, Scala V, Liorre G, Scarano F, Perrotta A, Farella N, Aloisio V, Mariniello N, Coppola C, Francica G and Ferraioli G: Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. AJR 181: 479-484, 2003. (Pubitemid 36909494)
15. Bruix J and Sherman M: Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellar carcinoma. An update. Official website of AASLD: www.asdl.org, 2010.
16. Forner A and Bruix J: Ablation for hepatocellular carcinoma: Is there need to have a winning technique? J Hepatol 52(3): 310-312, 2010.